OBJECTIVES: Oesophageal carcinoma (EC) remains an aggressive disease. Despite extensive changes in therapeutic modalities, surgical resection remains the first choice therapy for curable oesophageal cancer patients. Anastomotic sites are prone to serious complications such as leakage, fistula, bleeding and stricture. Leakage of the anastomosis (AL) remains one of the main causes of postoperative morbidity and mortality. The purpose of this study was to identify predictors associated with postoperative leakage after Ivor Lewis oesophagectomy and its consequences in a single centre.
INTRODUCTION
Over the past two decades, the incidence of oesophageal carcinoma (EC) is rapidly increasing, resulting in 480 000 newly diagnosed patients annually, making it the eighth most common cancer worldwide [1] . Despite extensive changes in therapeutic modalities and the introduction of neoadjuvant chemoradiation, surgical resection remains the standard therapy for curable oesophageal cancer patients.
Anastomotic sites are prone to serious complications such as leakage, fistula, bleeding and stricture. Pulmonary complications and failure of the oesophagogastric anastomotic site remain an important source of postoperative morbidity and mortality, despite a clear trend of decreasing incidences of both morbidity and mortality after oesophagectomy over the past decades. The reported leakage incidence after oesophagectomy ranges from 5% to up to 20%, with cervical anastomosis being more prone to leaks but most often with less leak-associated mortality [2] [3] [4] [5] [6] .
The leak-associated mortality after Ivor Lewis oesophagectomy is 18% compared with an overall in-hospital mortality of 6% [2, 7] .
Currently, two different surgical approaches are used: either a two-stage Ivor Lewis oesophagectomy with intrathoracic anastomosis, associated with low leakage of the anastomosis (AL) rates but potentially high morbidity and mortality, and a three-step approach with cervical anastomosis, associated with a higher AL rate but more manageable complications [3, 8] .
Several risk factors for AL have been identified such as age, male gender, emergency surgery, smoking, alcohol abuse, American Society of Anaesthesiologists (ASA) score, obesity, prolonged operative time, low serum albumin levels, intraoperative blood loss, diabetes, renal failure and cardiovascular disease [2, 4-6, 9, 10] .
Identifying preoperative predictors of outcome can provide important information for appropriate selection of patients. Moreover, they can become increasingly useful by allowing the surgeon to create a patient-tailored approach. The purpose of this study was to identify predisposing factors associated with AL and their consequences in patients after Ivor Lewis oesophagectomy for cancer.
PATIENTS AND METHODS

Patient selection
This study was granted permission by our institutional review board. It is a single-centre retrospective analysis based on data from a prospectively collected database and their medical records. We only included patients treated by Ivor Lewis oesophagectomy for oesophageal cancer between January 2005 and September 2014. All were treated at the Digestive Surgery unit at Ghent University Hospital, Belgium (Registration number B670201524241).
Ethics
Ethical approval for the creation and maintenance of an observational prospective database for patients after oesophageal resections. Belgian registration number: B670201111232.
This study was granted permission by our institutional review board (Registration number B670201524241. Ethical Committee of the Ghent University Hospital).
Data retrieval
All relevant data were retrieved from the database or extracted from the medical records and transferred into the research database. Follow-up was completed for all patients until death or date of censoring (1 April 2015) . Individual collected data included demographic data, personal history, type of neoadjuvant therapy, pathological response, perioperative blood loss, operative time, surgical complications, 30-day or in-hospital morbidity and mortality, local and metastatic recurrence rate, overall survival (OS).
Combined modality treatment
Clinical stage was based on the AJCC seventh edition cancer staging manual. Treatment modalities were discussed and defined by a multidisciplinary tumour board and based on the clinical staging.
Chemotherapy. Patients were treated with a cisplatin/5-Fluoracil (5-FU) or a carboplatinum-/paclitaxel-based chemo radiotherapy (CRT).
Radiotherapy. Neoadjuvant CRT consisted of 4-5 weeks of radiation combined with two to five episodes of chemo (Weeks 1 and 4 for cisplatin/5-FU or weekly for the carboplatinum/paclitaxel regimen). The radiation field covered the primary tumour with margins of 5 cm superiorly and inferiorly and 2 cm laterally to the tumour and the clinically positive nodes. A 4-to 6-week time span was kept between completion of neoadjuvant therapy and operation date. Total radiation dose was between 36 and 50 Gy according to the referring centre.
Surgery
Ivor Lewis subtotal oesophagectomy with two-field lymphadenectomy and a right intrathoracic oesophagogastric anastomosis was performed in all cases. All procedures were performed in a single institution by the same surgeon (Piet Pattyn). By laparotomy or laparoscopy, the stomach was released of its attachments. A thorough mobilization with Kocher manoeuvre was done to mobilize the stomach as the new conduit. Blood supply of the gastric remnant was based on the right gastric and gastro-epiploic artery. A gastric drainage pyloroplasty was performed and if indicated a jejunostomy was placed. Thorough lymph node dissection was done around the coeliac trunk and the splenic and hepatic artery was performed. Through a thoracotomy or thoracoscopy, we performed an en bloc oesophagectomy followed by a standardized circular gastroesophageal anastomosis at the level of the azygos vein using a Premium Plus CEEA™ (Covidien) anastomotic stapling device with a diameter of 25 or 28 mm. The minimally invasive approach was introduced in our centre in March 2014; in 8% of this study cohort, the procedure was done by this method.
Postoperative care
A nasogastric tube was kept in place during a period of 3-5 days. A water-soluble contrast swallow was done on the 3th-5th postoperative day as a routine screening before initiating oral intake. AL was identified and defined as minor when diagnosed only on radiological examination without clinical symptoms and thus treated conservatively, or as major when combined with associated signs and symptoms such as mediastinitis, inflammatory response or sepsis and requiring stenting or reintervention. Most leaks are identified based on their clinical presentation (t°, sepsis, … and confirmed on computed tomography scan) and often not visible on a water soluble, or they have been diagnosed before the water soluble was performed. The main reason to do the exam is to see passage of the contrast through the anastomosis and pylorus before starting realimentation, and second to exclude major leaks.
Statistical analysis
Continuous data were summarized with mean and standard deviation. Student's t-test was used to compare the mean of continuous data and Pearson's χ 2 test was used to compare categorical data, except for variables with expected values <5 for which Fisher's exact was used to determine statistical significance at the 5% level.
Significance of the different variables in the prediction of AL was assessed in univariable analysis and then significant factors were inserted in a multivariable logistic regression analysis. Odds ratios and relative risks were obtained from cross-tabulation. Covariates that were significantly correlated with leak in univariable analysis were simultaneously entered into the multivariable logistic regression model using the SPSS software.
Survival was measured from the date of surgery until death or end of study. OS was estimated using the Kaplan-Meier method, and the effect of AL on survival was analysed using univariable (log-rank test) analysis. Probability values of <0.05 were considered to indicate statistical significance. All analyses were performed using IBM SPSS® version 21 for Windows® and Sigmaplot® version 13 for Windows®.
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RESULTS
Demographics of the study cohort
Between January 2005 and September 2014, 412 of more than 600 oesophagectomy patients who met the inclusion criteria were identified.
Demographic data and their univariable association with AL are detailed in Table 1 . Mean age was 62 ± 11 years (77% male). Twelve patients (2.9%) experienced an anastomotic leak. Univariable analysis could not identify statistically significant differences in demographics between the patients with and without leakage ( Table 1 ). The majority of patients were treated for an adenocarcinoma (63%), 107 (30%) for a squamous cell carcinoma and 23 (7%) for high-grade dysplasia. Almost half of the patients were treated with neoadjuvant therapy, predominantly chemoradiation: mostly, cisplatinum + 5-FU + 36 Gy of radiation therapy (42% of patients), or the CROSS regimen (6% of patients). A total of 8% of patients were diagnosed with a gastroesophageal junction tumour protruding into the stomach and therefore received chemotherapy alone. No significant differences were seen between the two groups regarding tumour histology or neoadjuvant therapy. Most patients (69%) presented with a distal EC, 11% with a gastroesophageal junction tumour and 20% were operated for a midoesophageal cancer.
When looking at the preoperative patient characteristics, renal failure defined as a serum creatinine >1.5 mg/dl (P = 0.04), diabetes (P = 0.04), use of corticosteroids (P = 0.001) and active cigarette use (P = 0.02) were significantly more frequent in the AL group. In contrast, body mass index (BMI), significant weight loss between diagnosis and surgery (>5 kg) and a preoperative low serum albumin (<3 g/dl) are not statistically associated with AL. A history of cardiac disease, hypertension and the presence of oesophagitis also did not increase the risk of an AL. The ASA score on the other hand seemed a good prognostic factor for leakage on univariable analysis (P = 0.007) ( Table 2 ), but failed significance in the multivariable logistic regression model (Table 3) . (Table 3) .
Risk analysis
Surgical outcome and complications
All patients underwent surgery by the same surgeon. Median follow-up time was 27 months. Tumour resection was performed in all patients. Intraoperative blood transfusion was necessary in 4% of surgeries but this had no statistically significant influence on the risk of AL. Mean duration of surgery was 396 min and was associated with a trend towards a higher leak rate in univariable analysis (Table 4 ). Overall, 4% of patients had a positive resection margin on pathological examination. The percentages of positive resections margins were higher in the AL group (16%) compared with the non-AL group (3%), but it did not reach statistical significance in univariable analysis (P = 0.07). Mean intensive care unit (ICU) stay was 4 days and mean hospital stay was 19 days, both were significantly higher in the AL group (22 vs 4 days, P = 0.02 and 54 vs 18 days, P = 0.01). In-hospital or 30-day mortality was 4% after oesophagectomy, again with a significantly higher mortality in the group of patients with an AL (42 vs 3%, P < 0.0001). Severe stenosis of the anastomosis in need of dilatation was found in 6% of patients, and this was not influenced by the presence of a postoperative AL. Of the 412 patients, 236 patients (57%) are still alive. Median OS for patients without AL was 41 months (range 0-120) compared with 3 months (range 0-45) for the AL group. In log-rank analysis (Fig. 1) , an AL after Ivor Lewis oesophagectomy was associated with a significantly worse OS (1-and 5-year OS without AL is 80 and 44% vs 33 and 0% after AL, P < 0.001) ( Table 5) .
Of the 12 patients who presented with an AL, 6 were treated within 1 week after surgery by a reintervention.
One patient had a necrosis of the proximal stomach requiring partial resection and creation of a new anastomosis. In all but one of the reoperated patients, an anastomosis was present at the end of the revision (either by primary closer of the gap or by creating a new anastomosis). In 1 patient, the entire construction was taken down due to major inflammation (the presence and revision for leak was 1 month after primary surgery), a cervicostomy and a gastrostomy were created. The stomach was severely damaged due to inflammation but vital and only partially resected.
Three died 2 months after reintervention at the ICU due to sepsis, brain damage after a cardiac arrest and one after a request from the family to stop active therapy, no active leaks were found at imagery at the time of death. Two died years later from disease recurrence. One patient is still alive. Three patients were treated by stenting. One was reoperated, but again demonstrated a leak, recovered from it but finally died 5 months after surgery due to peritoneal carcinomatosis. A second patient died 3 months after surgery at the ICU from multiple organ failure, images showed no active leak at that time. The third stented patient was reoperated after stenting for a persistent leak, recovered but died 3. 5 months after surgery after a request from the patient and his family to stop active therapy. Finally, 3 patients were treated conservatively, 2 with good results, 1 died in a referring hospital 1 month after surgery without any further interventions.
DISCUSSION
Despite extensive changes in therapeutic modalities, surgical resection remains the standard therapy for patients with curable oesophageal cancer, even for those with a locally advanced form. Pulmonary complications and leakage of the oesophagogastric anastomotic site remain the two most important postoperative complications associated with a significant morbidity and mortality [2, 7] . Identifying potential predictors of outcome preoperatively can provide opportunities to improve these preoperative conditions, and it can provide important information for appropriate selection of patients. Moreover, it can change the therapeutic strategy favouring a non-surgical management (definitive chemoradiation) for high-risk patients. Leakage was present in 2.9% of this study population. This number compares favourably with leak rates of between 5 and 9% after the Ivor Lewis procedure in the recent literature [2, 3, 7, 8] . Univariable analysis identified ASA as a reliable predictive score for AL. Multivariable analysis, however, could not confirm this trend. Multiple studies have shown a statistically significant association between a higher postoperative morbidity and mortality, but most authors were unable to detect an association between ASA score and AL rate [6, 9] , suggesting that ASA is reliable in the prediction of postoperative morbidity due to pneumonia but is less reliable for the prediction of AL.
Kassis et al. suggested that disease processes compromising anastomotic perfusion are major predictors of AL and should be treated before planning a surgical procedure [2] . We could not identify a history of cardiac condition or hypertension to be a significant risk factor; however, their presence was rare among our patients suggesting a careful patient selection preoperatively. Diabetes, renal failure and smoking, on the other hand, did reach statistical significance in univariable analysis, and this was confirmed for diabetes and smoking in multivariable analysis, similar to the findings of Kassis and Wright [2, 9] .
Active use of corticosteroids at the time of surgery is identified both in univariable and in multivariable analyses as a significant risk factor for AL, similar to the findings of Kassis, when identifying predictors of AL on the society of thoracic surgeons' general thoracic database [2] . Wright, on the other hand, could not identify steroid use as a risk factor for major morbidity and mortality in univariable analysis, but he did confirm a significant causal effect in multivariable analysis [9] .
The mean age of our population was 62, comparable with other series. Higher age has been suggested as an important predictor of outcome after oesophageal resection [4, 9] . We, however, did not find a correlation between higher age and AL, neither in univariable (P = 0.1) nor in multivariable analysis (P = 0.08), as confirmed by Kassis et al. [2] . Multiple studies have shown a significant correlation between age and postoperative pneumonia and mortality but most of the series up until now could not show a significant association between age and AL [4, 9] . Therefore, one should be careful in using age as a limiting factor in the therapeutic choices when treating EC.
Nutrition in patients with EC is often compromised and malnutrition was suggested as a risk factor for AL [5] . We however could not identify a correlation between AL and preoperative hypoalbuminaemia, severe weight loss preoperatively or low BMI. This, however, could probably be explained by the limited amount of patients with severe cachexia (BMI <17 kg/m 2 ) and low serum albumin (<3 g/dl).
For Stage III EC, neoadjuvant chemoradiation has increased OS and disease-free survival, and as more patients undergo radiotherapy and/or chemotherapy before surgery, it is reassuring that no association could be found between AL and neoadjuvant RCT, a finding confirmed by the Society of Thoracic Surgeons General Thoracic database and other larger series [2, 4, 7, 9] . This is a retrospective analysis primarily performed to evaluate our current approach in oesophageal cancer therapy. The low rate of anastomotic leaks was reassuring and suggests a thorough patient selection. On the basis of the results, we advocate a comprehensive risk analysis at the outpatient clinic and for those with combined risk factors (diabetes, renal failure, corticotherapy and smoking). The option of definitive chemoradiation instead of neoadjuvant chemoradiation and surgery needs to be discussed with the patient. Moreover, we plan to analyse the predictive value of the Estimation of Physiologic Ability and Surgical Stress and total risk points score on our dataset and if proven useful, we will include it in our preoperative risk analysis.
Finally, we noted a significantly longer ICU and hospital stay after AL. Reducing AL rates by identifying patients at risk before surgery may therefore be an important tool in reducing hospital costs associated with oesophageal surgery. Most studies report mortality rates after intrathoracic AL between 20 and 35% [7] . Sauvanet reported AL as the most frequent cause of postoperative death [4] . Overall 30-day or in-hospital mortality was 4%, well within the range accepted by the literature [9, [11] [12] [13] [14] [15] . The 30-day or in-hospital mortality for AL patients however was 42% compared with 3% in the control group (P < 0.0001), with an odds ratio suggesting a 21-fold increased risk of postoperative death following AL. An AL-associated mortality rate is almost double than that of most series of Ivor Lewis resections in the literature [4, 7, 10] . Part of it is due to the fact that this is an in-hospital mortality compared with the 30-day mortality which is often described in the literature. None of those 12 patients with an AL died within 30 days. Five of the 12 AL patients died in hospital but between 2 and 3.5 months after surgery. Of these 5 patients, 3 died after a request from the family to stop active therapy. Nevertheless, we realize that if we want to improve as a centre, improving AL-associated mortality is the biggest challenge.
Leakages may vary in severity and some can be treated conservatively whereas others need a reintervention. Our group of AL patients, however, was so limited that it did not allow us to stratify leakage into different categories.
In this retrospective analysis, the decision to operate was individual and not according to a protocol. Analysis of AL treatment favours, in our opinion, a fast and aggressive approach instead of stenting. But as already mentioned, the amount of leaks is limited and therefore not conclusive.
We did not analyse a time effect in this study cohort, as very little has changed in our standard of care for oesophageal surgery. The only major change in surgical procedure over time is the start of the minimally invasive oesophageal surgery in March 2014 in our centre; however, only 33 patients (<10%) in this group were operated using the minimally invasive approach, and none of them presented with a leak. Therefore, we did not include this variable in this study cohort.
Several restrictions apply in the interpretation of our results. Firstly, data were collected retrospectively, and this entails the risk of confounding and bias. Secondly, the number of events was quite low, resulting in rather imprecise risk estimation as evidenced by the wide confidence intervals around the estimates of the odds ratios. Nevertheless, our findings may contribute to a careful patient selection, preoperative medical optimization and high postoperative awareness for AL-risk patients to improve outcome after Ivor Lewis oesophagectomy.
In conclusion, anastomotic leakage after Ivor Lewis oesophagectomy is associated with a prolonged ICU and hospital stay, and a significantly higher mortality. Identifying AL-associated risk factors preoperatively can contribute to a better selection of patients, optimizing preoperative conditions and a more patienttailored approach.
